These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24557022)

  • 1. Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: a randomised, controlled study.
    Faraoni D; Cacheux C; Van Aelbrouck C; Ickx BE; Barvais L; Levy JH
    Eur J Anaesthesiol; 2014 Sep; 31(9):491-8. PubMed ID: 24557022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation.
    Zhou ZF; Zhai W; Yu LN; Sun K; Sun LH; Xing XF; Yan M
    BMC Anesthesiol; 2021 Feb; 21(1):33. PubMed ID: 33530942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass.
    Couturier R; Rubatti M; Credico C; Louvain-Quintard V; Anerkian V; Doubine S; Vasse M; Grassin-Delyle S
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):259-65. PubMed ID: 24418941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.
    Casati V; Della Valle P; Benussi S; Franco A; Gerli C; Baili P; Alfieri O; D'Angelo A
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):83-91. PubMed ID: 15224025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial.
    Bouthors AS; Hennart B; Jeanpierre E; Baptiste AS; Saidi I; Simon E; Lannoy D; Duhamel A; Allorge D; Susen S
    Trials; 2018 Mar; 19(1):148. PubMed ID: 29490682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial.
    Ducloy-Bouthors AS; Jeanpierre E; Saidi I; Baptiste AS; Simon E; Lannoy D; Duhamel A; Allorge D; Susen S; Hennart B
    Trials; 2018 Mar; 19(1):149. PubMed ID: 29490690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
    Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial.
    Jiménez JJ; Iribarren JL; Brouard M; Hernández D; Palmero S; Jiménez A; Lorente L; Machado P; Borreguero JM; Raya JM; Martín B; Pérez R; Martínez R; Mora ML
    J Cardiothorac Surg; 2011 Oct; 6():138. PubMed ID: 21999189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation.
    Kaspar M; Ramsay MA; Nguyen AT; Cogswell M; Hurst G; Ramsay KJ
    Anesth Analg; 1997 Aug; 85(2):281-5. PubMed ID: 9249100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ; Nielsen C
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury.
    Dixon AL; McCully BH; Rick EA; Dewey E; Farrell DH; Morrison LJ; McMullan J; Robinson BRH; Callum J; Tibbs B; Dries DJ; Jui J; Gandhi RR; Garrett JS; Weisfeldt ML; Wade CE; Aufderheide TP; Frascone RJ; Tallon JM; Kannas D; Williams C; Rowell SE; Schreiber MA
    J Trauma Acute Care Surg; 2020 Nov; 89(5):900-907. PubMed ID: 33105308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting.
    Santos AT; Kalil RA; Bauemann C; Pereira JB; Nesralla IA
    Braz J Med Biol Res; 2006 Jan; 39(1):63-9. PubMed ID: 16400465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study.
    Lundin ES; Johansson T; Zachrisson H; Leandersson U; Bäckman F; Falknäs L; Kjølhede P
    Acta Obstet Gynecol Scand; 2014 Apr; 93(4):335-44. PubMed ID: 24428857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topical tranexamic acid in open heart surgery.
    Abul-Azm A; Abdullah KM
    Eur J Anaesthesiol; 2006 May; 23(5):380-4. PubMed ID: 16438759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial.
    Karski JM; Teasdale SJ; Norman P; Carroll J; VanKessel K; Wong P; Glynn MF
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):835-42. PubMed ID: 7564453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass.
    Sigaut S; Tremey B; Ouattara A; Couturier R; Taberlet C; Grassin-Delyle S; Dreyfus JF; Schlumberger S; Fischler M
    Anesthesiology; 2014 Mar; 120(3):590-600. PubMed ID: 23903022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.